⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SER News
Serina Therapeutics, Inc.
Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
SER
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
globenewswire.com
SER
Form 8-K
sec.gov
SER
Form 8-K
sec.gov
SER
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
SER
Form 8-K
sec.gov
SER
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
globenewswire.com
SER
Form 8-K
sec.gov
SER
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
globenewswire.com
SER
Form 8-K
sec.gov
SER